Astera Labs Inc (ALAB) concluded trading on Wednesday at a closing price of $92.17, with 5.4 million shares of worth about $497.89 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 6.62% during that period and on May 21, 2025 the price saw a loss of about -2.42%. Currently the company’s common shares owned by public are about 164.91M shares, out of which, 124.25M shares are available for trading.
Stock saw a price change of 1.67% in past 5 days and over the past one month there was a price change of 66.64%. Year-to-date (YTD), ALAB shares are showing a performance of -30.41% which increased to 27.13% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $36.22 but also hit the highest price of $147.39 during that period. The average intraday trading volume for Astera Labs Inc shares is 4.31 million. The stock is currently trading 19.39% above its 20-day simple moving average (SMA20), while that difference is up 34.34% for SMA50 and it goes to 16.80% higher than SMA200.
Astera Labs Inc (NASDAQ: ALAB) currently have 164.91M outstanding shares and institutions hold larger chunk of about 60.43% of that.
The stock has a current market capitalization of $15.20B and its 3Y-monthly beta is at 1.30. PE ratio of stock for trailing 12 months is 392.88, while it has posted earnings per share of $0.23 in the same period. Its PEG reads 9.22 and has Quick Ratio of 13.26 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ALAB, volatility over the week remained 5.32% while standing at 5.66% over the month.
Stock’s fiscal year EPS is expected to rise by 60.00% while it is estimated to increase by 27.71% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Susquehanna on May 16, 2025 offering a Neutral rating for the stock and assigned a target price of $80 to it. Coverage by Morgan Stanley stated Astera Labs Inc (ALAB) stock as an Overweight in their note to investors on May 12, 2025, suggesting a price target of $99 for the stock. On March 14, 2025, Raymond James Initiated their recommendations, while on January 28, 2025, Northland Capital Upgrade their ratings for the stock with a price target of $120. Stock get an Equal-weight rating from Morgan Stanley on January 21, 2025.
